Français

Mental Wellness Program

Bio-Paroxétine paroxetine

Evaluated tools to help you understand your treatment, track what changes and know who to talk to.

Selective serotonin reuptake inhibitor (SSRI) · ATC N06AB05

These tools apply to every medication containing paroxetine, whatever the manufacturer.

Where are you in your treatment?

Essentials to get started

Tools by topic

Understand your treatment

How paroxetine works, and what to expect.

Take care of yourself day to day

Therapy, stress management and support, at your own pace.

  • Website

    Relief — self-management workshops

    10- to 12-week group workshops, online or in person in several Quebec regions, to live better with anxiety, depression or bipolar disorder.

    ReliefFree

  • Website

    Bounce Back

    Guided self-help program: phone coaching, practical workbooks and short videos to manage low mood, stress and anxiety.

    Canadian Mental Health Association (CMHA) – Quebec DivisionFree

  • Video

    Building connections and being well surrounded

    Why social connections protect mental health, with practical ideas to build and keep them.

    Mouvement Santé mentale QuébecFree

  • App

    Prezens

    Short breathing, meditation and mindfulness exercises to pause and find calm.

    Emergence asblFree

  • App

    MindDay

    Daily online coaching based on recognized strategies and mindfulness, to better understand thoughts and emotions.

    mindDay SASPaid or limited trial

  • Website

    Équilia — CBT and mindfulness program

    Free, self-paced 6-lesson online program combining cognitive behavioural therapy and mindfulness. No waiting list.

    Équilia research team (CIHR project, Quebec–Ontario collaboration)Free

Track what changes

Note how you feel to see how things evolve, and bring it to your appointments.

  • App

    Daylio

    Mood journal: log how you feel and what you did, then spot patterns. Handy to bring to your appointments.

    Relaxio s.r.o.Limited free version

  • Website

    MesOutils.ca

    Free Quebec platform: journal, exercises, questionnaires and a safety plan to get through difficult times.

    Association québécoise de prévention du suicide (AQPS) / CETI-SMDIFree

Know when to call

What is expected, what should make you call, and who to contact.

  • Article

    Understanding antidepressant medications, part 1: how to use them safely

    What antidepressants do, how long they take to work, and which side effects are common at the start.

    Canadian Medication Appropriateness and Deprescribing Network (CADeN)Free

  • Article

    Drugs for treatment of depression

    Consumer reference on antidepressant classes, how they act, and their side effects.

    Merck Manual (Consumer Version)Free

  • Website

    MesOutils.ca

    Free Quebec platform: journal, exercises, questionnaires and a safety plan to get through difficult times.

    Association québécoise de prévention du suicide (AQPS) / CETI-SMDIFree

Bio-Paroxétine products

DIN Strength Form DPD status Program
02444909 10 mg TABLET Marketed Yes
02444917 20 mg TABLET Marketed Yes
02444925 30 mg TABLET Marketed Yes

Other paroxetine DINs on the market 58

58 products from other manufacturers. If your DIN is in this list, the tools on this page apply to you too.

DIN BrandManufacturer Strength Form DPD status
02477823 PAROXETINEALTAMED PHARMA 10 mg TABLET Marketed
02477831 PAROXETINEALTAMED PHARMA 20 mg TABLET Marketed
02477858 PAROXETINEALTAMED PHARMA 30 mg TABLET Marketed
02475537 AG-PAROXETINEANGITA PHARMA INC. 10 mg TABLET Dormant (not currently sold)
02510480 AG-PAROXETINE TABLETSANGITA PHARMA INC. 10 mg TABLET Marketed
02475545 AG-PAROXETINEANGITA PHARMA INC. 20 mg TABLET Dormant (not currently sold)
02510499 AG-PAROXETINE TABLETSANGITA PHARMA INC. 20 mg TABLET Marketed
02475553 AG-PAROXETINEANGITA PHARMA INC. 30 mg TABLET Dormant (not currently sold)
02510510 AG-PAROXETINE TABLETSANGITA PHARMA INC. 30 mg TABLET Marketed
02240907 APO-PAROXETINEAPOTEX INC 10 mg TABLET Marketed
02240908 APO-PAROXETINEAPOTEX INC 20 mg TABLET Marketed
02240909 APO-PAROXETINEAPOTEX INC 30 mg TABLET Marketed
02383276 AURO-PAROXETINEAURO PHARMA INC 10 mg TABLET Marketed
02383284 AURO-PAROXETINEAURO PHARMA INC 20 mg TABLET Marketed
02383292 AURO-PAROXETINEAURO PHARMA INC 30 mg TABLET Marketed
02248503 PAXIL CRGLAXOSMITHKLINE INC 12.5 mg TABLET (EXTENDED-RELEASE) Marketed
01940481 PAXIL TAB 20MGGLAXOSMITHKLINE INC 20 mg TABLET Marketed
02248504 PAXIL CRGLAXOSMITHKLINE INC 25 mg TABLET (EXTENDED-RELEASE) Marketed
02368862 JAMP-PAROXETINEJAMP PHARMA CORPORATION 10 mg TABLET Dormant (not currently sold)
02507773 JAMP PAROXETINE TABLETSJAMP PHARMA CORPORATION 10 mg TABLET Marketed
02368870 JAMP-PAROXETINEJAMP PHARMA CORPORATION 20 mg TABLET Dormant (not currently sold)
02507781 JAMP PAROXETINE TABLETSJAMP PHARMA CORPORATION 20 mg TABLET Marketed
02368889 JAMP-PAROXETINEJAMP PHARMA CORPORATION 30 mg TABLET Dormant (not currently sold)
02507803 JAMP PAROXETINE TABLETSJAMP PHARMA CORPORATION 30 mg TABLET Marketed
02248559 RIVA-PAROXETINELABORATOIRE RIVA INC. 10 mg TABLET Marketed
02248560 RIVA-PAROXETINELABORATOIRE RIVA INC. 20 mg TABLET Marketed
02248561 RIVA-PAROXETINELABORATOIRE RIVA INC. 30 mg TABLET Marketed
02467402 M-PAROXETINEMANTRA PHARMA INC 10 mg TABLET Marketed
02467410 M-PAROXETINEMANTRA PHARMA INC 20 mg TABLET Marketed
02467429 M-PAROXETINEMANTRA PHARMA INC 30 mg TABLET Marketed
02410834 IPG-PAROXETINEMARCAN PHARMACEUTICALS INC 10 mg TABLET Approved, not yet marketed
02411946 MAR-PAROXETINEMARCAN PHARMACEUTICALS INC 10 mg TABLET Marketed
02410842 IPG-PAROXETINEMARCAN PHARMACEUTICALS INC 20 mg TABLET Approved, not yet marketed
02411954 MAR-PAROXETINEMARCAN PHARMACEUTICALS INC 20 mg TABLET Marketed
02410850 IPG-PAROXETINEMARCAN PHARMACEUTICALS INC 30 mg TABLET Approved, not yet marketed
02411962 MAR-PAROXETINEMARCAN PHARMACEUTICALS INC 30 mg TABLET Marketed
02421372 MINT-PAROXETINEMINT PHARMACEUTICALS INC 10 mg TABLET Marketed
02421380 MINT-PAROXETINEMINT PHARMACEUTICALS INC 20 mg TABLET Marketed
02421399 MINT-PAROXETINEMINT PHARMACEUTICALS INC 30 mg TABLET Marketed
02479753 NRA-PAROXETINENORA PHARMA INC 10 mg TABLET Marketed
02479761 NRA-PAROXETINENORA PHARMA INC 20 mg TABLET Marketed
02479788 NRA-PAROXETINENORA PHARMA INC 30 mg TABLET Marketed
02247750 PMS-PAROXETINEPHARMASCIENCE INC 10 mg TABLET Marketed
02247751 PMS-PAROXETINEPHARMASCIENCE INC 20 mg TABLET Marketed
02247752 PMS-PAROXETINEPHARMASCIENCE INC 30 mg TABLET Marketed
02293749 PMS-PAROXETINEPHARMASCIENCE INC 40 mg TABLET Dormant (not currently sold)
02248913 PRO-PAROXETINEPRO DOC LIMITEE 10 mg TABLET Marketed
02248914 PRO-PAROXETINEPRO DOC LIMITEE 20 mg TABLET Marketed
02248915 PRO-PAROXETINEPRO DOC LIMITEE 30 mg TABLET Marketed
02282844 PAROXETINESANIS HEALTH INC 10 mg TABLET Marketed
02282852 PAROXETINESANIS HEALTH INC 20 mg TABLET Marketed
02282860 PAROXETINESANIS HEALTH INC 30 mg TABLET Marketed
02388227 PAROXETINESIVEM PHARMACEUTICALS ULC 10 mg TABLET Marketed
02388235 PAROXETINESIVEM PHARMACEUTICALS ULC 20 mg TABLET Marketed
02388243 PAROXETINESIVEM PHARMACEUTICALS ULC 30 mg TABLET Marketed
02248556 TEVA-PAROXETINETEVA CANADA LIMITED 10 mg TABLET Marketed
02248557 TEVA-PAROXETINETEVA CANADA LIMITED 20 mg TABLET Marketed
02248558 TEVA-PAROXETINETEVA CANADA LIMITED 30 mg TABLET Marketed

For pharmacists and healthcare professionals

Every tool was evaluated against public criteria. You can share this page directly with your patients: no DIN is required.